Cyclophosphamide in the management of advanced bronchial carcinoma.
作者信息
McLean R D
出版信息
Thorax. 1965 Nov;20(6):555-61. doi: 10.1136/thx.20.6.555.
Abstract
摘要
相似文献
1
Cyclophosphamide in the management of advanced bronchial carcinoma.环磷酰胺在晚期支气管癌治疗中的应用
Thorax. 1965 Nov;20(6):555-61. doi: 10.1136/thx.20.6.555.
2
[Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].[晚期支气管癌的近期个人治疗结果。姑息性免疫化疗。63例]
Ann Med Interne (Paris). 1976 Jan;127(1):39-42.
3
[On the treatment of inoperable bronchial cancer].
Med Klin. 1969 Apr 4;64(14):634-7.
4
Cyclophosphamide in disseminated bronchial carcinoma.环磷酰胺用于播散性支气管癌
Scott Med J. 1974 Mar;19(2):81-6. doi: 10.1177/003693307401900204.
5
[Cytostatic therapy of bronchial carcinoma].
Dtsch Med Wochenschr. 1972 Apr 14;97(15):618-9. doi: 10.1055/s-0028-1107409.
6
[Three years of experience in the polychemotherapy of inoperable bronchial carcinoma].[不可切除支气管癌多药化疗的三年经验]
Wien Med Wochenschr. 1974 Jul 27;124(30):467-73.
7
[Endoxan treatment in cases of inoperable bronchial carcinoma].[不可切除支气管癌病例的环磷酰胺治疗]
Gruzlica. 1975 Aug;43(8):737-41.
8
[Prognosis of inoperable bronchial carcinomas managed through a combination of cytostatic- and radiotherapy].[通过细胞抑制剂与放疗联合治疗不可切除支气管癌的预后]
Zentralbl Chir. 1974 Jun;99(22):690-4.
9
[Cyclophosphamide therapy of bronchial carcinoma].[支气管癌的环磷酰胺治疗]
Med Klin. 1966 Apr 15;61(15):586-92.
10
[Chemotherapy of bronchial cancer].
Plucne Bolesti Tuberk. 1974;26 Suppl 2:356-7.
引用本文的文献
1
Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.C9orf72 肌萎缩侧索硬化症/额颞叶痴呆的发病机制和治疗进展。
Neurotherapeutics. 2019 Oct;16(4):1115-1132. doi: 10.1007/s13311-019-00797-2.
2
Hair disorders in patients with cancer.癌症患者的毛发疾病。
J Am Acad Dermatol. 2019 May;80(5):1179-1196. doi: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14.
本文引用的文献
1
Comparative clinical evaluation of two alkylating agents: mannitol mustard and cyclophosphamide (cytoxan).两种烷化剂的比较临床评估：甘露醇氮芥与环磷酰胺（癌得星）。
J Am Med Assoc. 1960 Mar 26;172:1387-91. doi: 10.1001/jama.1960.63020130004012.
2
The response of various types of bronchogenic carcinoma to nitrogen mustard.各类支气管源性癌对氮芥的反应。
Ann Intern Med. 1955 May;42(5):1089-96. doi: 10.7326/0003-4819-42-5-1089.
3
CYTOTOXIC DRUGS IN BRONCHIAL CARCINOMA.支气管癌中的细胞毒性药物
Lancet. 1964 Dec 5;2(7371):1200-1. doi: 10.1016/s0140-6736(64)91040-2.
4
CYCLOPHOSPHAMIDE IN MALIGNANT DISEASE.
Lancet. 1964 Jan 11;1(7324):77-9. doi: 10.1016/s0140-6736(64)91393-5.
5
[Trials in endoxan therapy].[环磷酰胺治疗试验]
Munch Med Wochenschr. 1961 Nov 3;103:2160-3.
6
Oat cell lung cancer.燕麦细胞肺癌
Cancer. 1962 Jul-Aug;15:759-68. doi: 10.1002/1097-0142(196207/08)15:4<759::aid-cncr2820150410>3.0.co;2-6.
7
Clinical experience with cyclophosphamide in malignant disease.环磷酰胺治疗恶性疾病的临床经验。
Can Med Assoc J. 1961 Oct 28;85(18):974-86.
8
Cyclophosphamide in treatment of disseminated malignant disease.环磷酰胺治疗播散性恶性疾病。
Br Med J. 1961 Dec 9;2(5266):1516-23. doi: 10.1136/bmj.2.5266.1516.
9
[Clinical experiences with endoxan].[环磷酰胺的临床经验]
Munch Med Wochenschr. 1959 Dec 4;101:2273-5.
10
A prelusive clinical trial of cyclophosphamide.环磷酰胺的一项初步临床试验。
Cancer Chemother Rep. 1960 Jul;8:120-34.
Zotero 插件